ereprof. dr. Claus Bachert

Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2) : phase 3, randomised, double-blind, parallel trials

Philippe Gevaert (UGent) , Martin Desrosiers, Marjolein Cornet, Joaquim Mullol, Eugenio De Corso, Nesil Keles Turel, Jorge Maspero, Shigeharu Fujieda, Luo Zhang, Ana R Sousa, et al.

(2025) LANCET. 405(10482). p.911-926

Add to list

Journal Article
A1
open access

The alphaherpesvirus gE/gI glycoprotein complex and proteases jointly orchestrate invasion across the host’s upper respiratory epithelial barrier

Eline Van Crombrugge (UGent) , Xiaolei Ren (UGent) , Sarah Glorieux (UGent) , Ines Zarak (UGent) , Wim Van Den Broeck (UGent) , Claus Bachert (UGent) , Nan Zhang (UGent) , Thibaut Van Zele (UGent) , D. Kim, G. A. Smith, et al.

(2024) MBIO. 15(11).

Add to list

Journal Article
A1
open access

Dupilumab response onset, maintenance, and durability in patients with severe CRSwNP

Claus Bachert (UGent) , Asif H. Khan, Wytske J. Fokkens, Claire Hopkins, Philippe Gevaert (UGent) , Joseph K. Han, Peter Hellings (UGent) , Stella E. Lee, Jérôme Msihid, Scott Nash, et al.

(2024) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 154(6). p.1442-1449

Add to list

Endoskopisches Scoring von Nasenpolypen : executive Summary des EAACI-Positionspapiers : European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis

L. Klimek, Philippe Gevaert (UGent) , Claus Bachert (UGent) , R. Mösges, M. Wagenmann, P.V. Tomazic and A. Chaker

(2024) ALLERGOLOGIE. 47(3). p.133-139

Add to list

Journal Article
A1
open access

The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps

Claus Bachert (UGent) , Alexandra Hicks, Simon Gane, Anju T. Peters, Philippe Gevaert (UGent) , Scott Nash, Julie E. Horowitz, Harry Sacks and Juby A. Jacob-Nara

(2024) FRONTIERS IN IMMUNOLOGY. 15.

Add to list

Journal Article
A1
open access

Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis

Claus Bachert (UGent) , Philippe Gevaert (UGent) , Brian Lipworth, Syed Shahzad Mustafa, Andrew P. Lane, Joaquim Mullol, Paul Rowe, Yamo Deniz, Siddhesh Kamat, Asif H. Khan, et al.

(2024) ALLERGY. 79(10). p.2858-2861

Add to list

Choice of surgery in intestinal-type adenocarcinoma of the sinonasal tract : a long-term comparative study

Tijl Vermassen (UGent) , Stijn De Keukeleire (UGent) , Michael Saerens (UGent) , Sylvester Heerwegh, Jens Debacker (UGent) , Wouter Huvenne (UGent) , Philippe Deron (UGent) , David Creytens (UGent) , Liesbeth Ferdinande (UGent) , Sylvie Rottey (UGent) , et al.

(2024) EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 281(6). p.2993-3004

Add to list

MZB1-expressing cells are essential for local immunoglobulin production in chronic rhinosinusitis with nasal polyps

Yanran Huang (UGent) , Zhaofeng Xu (UGent) , Gabriële Holtappels (UGent) , Yang Shen, Thibaut Van Zele (UGent) , Weiping Wen, Luo Zhang, Nan Zhang (UGent) and Claus Bachert (UGent)

(2024) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. 132(2). p.198-207.e14

Add to list

Chronic rhinosinusitis outcome registry (CHRINOSOR) : establishment of an international outcome registry driven by mHealth technology

Sven F. Seys, Peter Hellings (UGent) , Isam Alobid, Vibeke Backer, Emilie Bequignon, Christian von Buchwald, Carlo Cavaliere, André Coste, Lauren Deneyer, Zuzana Diamant, et al.

(2023) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 11(2). p.431-438.e2

Add to list

Journal Article
A1
open access

The unified airway hypothesis : evidence from specific intervention with anti–IL-5 biologic therapy

Claus Bachert (UGent) , Amber U. Luong, Philippe Gevaert (UGent) , Joaquim Mullol, Steven G. Smith, Jared Silver, Ana R. Sousa, Peter H. Howarth, Victoria S. Benson, Bhabita Mayer, et al.

(2023) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 11(9). p.2630-2641

Academic Bibliography

ereprof. dr. Claus Bachert

Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2) : phase 3, randomised, double-blind, parallel trials

The alphaherpesvirus gE/gI glycoprotein complex and proteases jointly orchestrate invasion across the host’s upper respiratory epithelial barrier

Dupilumab response onset, maintenance, and durability in patients with severe CRSwNP

Endoskopisches Scoring von Nasenpolypen : executive Summary des EAACI-Positionspapiers : European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis

The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps

Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis

Choice of surgery in intestinal-type adenocarcinoma of the sinonasal tract : a long-term comparative study

MZB1-expressing cells are essential for local immunoglobulin production in chronic rhinosinusitis with nasal polyps

Chronic rhinosinusitis outcome registry (CHRINOSOR) : establishment of an international outcome registry driven by mHealth technology

The unified airway hypothesis : evidence from specific intervention with anti–IL-5 biologic therapy

Contents

Support

Contact